PNC Financial Services Group’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
PNC Financial Services Group's ORKA Position: Q3 2026 in Review
PNC Financial Services Group increased its Oruka Therapeutics (ORKA) stake by 37% in Q3 2026, buying an estimated $147K and bringing the position to 5,790 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #1850.
PNC Financial Services Group first reported a position in ORKA in Q2 2023 and has held it in 6 quarters since. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.
- PNC Financial Services Group held 5,790 shares of Oruka Therapeutics worth $482K as of Q3 2026.
- PNC Financial Services Group bought 1,565 Oruka Therapeutics shares in Q3 2026, an estimated $147K.
- Oruka Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #1850 holding.
- PNC Financial Services Group first reported a position in Oruka Therapeutics in Q2 2023 and has held it in 6 quarters since.
- 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.